Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study

QR Code

Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study

Jordi Gatell-TortajadaOn behalf of the Large Dry Eye Clinical Study Group (LDECSG)Cornea and Ocular Surface Department, Institut Català de Retina, Barcelona, SpainPurpose: To assess the benefits and tolerability of a dietary supplement based on omega-3 fatty acids to relieve dry eye sympt...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Gatell-Tortajada J
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2016
Sujets:	dry eye symptoms artificial tears omega-3 polyunsaturated fatty acids nutraceutical supplement ocular inflammation eye discomfort oxidative stress. Geriatrics RC952-954.6
Accès en ligne:	https://doaj.org/article/692b039cb4b04e7da5f5ea373da6e2ee
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study
par: Tellez-Vazquez J
Publié: (2016)

Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders
par: Pinazo-Durán MD, et autres
Publié: (2013)

Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study
par: Kaya A, et autres
Publié: (2016)

Effects of short-term oral vitamin A supplementation on the ocular tear film in patients with dry eye
par: Alanazi SA, et autres
Publié: (2019)

Changes in Tear Lipid Layer Thickness and Symptoms Following the Use of Artificial Tears with and Without Omega-3 Fatty Acids: ARandomized, Double-Masked, Crossover Study
par: Fogt JS, et autres
Publié: (2019)

Investigating the potential benefits of a new artificial tear formulation combining two polymers
par: Simmons PA, et autres
Publié: (2017)

Dynamics of tear fluid desiccation on a glass surface: a contribution to tear quality assessment
par: Traipe-Castro,Leonidas, et autres
Publié: (2014)

Effect of Refresh Plus® preservative-free lubricant eyedrops on tear ferning patterns in dry eye and normal eye subjects
par: Alanazi SA, et autres
Publié: (2019)

Patient-reported severity of dry eye and quality of life in diabetes
par: Yazdani-Ibn-Taz MK, et autres
Publié: (2019)

Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity
par: Pepose JS, et autres
Publié: (2019)

Progress in tear microdesiccate analysis by combining various transmitted-light microscope techniques
par: Traipe-Salas,Felipe, et autres
Publié: (2016)

Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye
par: Torkildsen G, et autres
Publié: (2017)

Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial
par: Silverstein S, et autres
Publié: (2020)

Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial
par: Yeu E, et autres
Publié: (2020)

A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction
par: Oleñik A, et autres
Publié: (2013)

Improved Dry Eye Symptoms and Signs of Patients With Meibomian Gland Dysfunction by a Dietary Supplement
par: Kangcheng Liu, et autres
Publié: (2021)

Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
par: Ryu KJ, et autres
Publié: (2021)

Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops
par: Ng A, et autres
Publié: (2018)

Stimulating Tear Production: Spotlight on Neurostimulation
par: Yu MD, et autres
Publié: (2021)

Protecting the Ocular Surface in Cataract Surgery: The Efficacy of the Perioperative Use of a Hydroxypropyl Guar and Hyaluronic Acid Ophthalmic Solution
par: Favuzza E, et autres
Publié: (2020)

Evaluation of Tear Film Urea Level as a Diagnostic Marker of Dry Eye Disease: A Pilot Study
par: Gurunadh Satyanarayana Velamakanni, et autres
Publié: (2021)

Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients
par: Miyake H, et autres
Publié: (2016)

Safety and efficacy of lifitegrast 5% ophthalmic solution in contact lens discomfort
par: Gonzalez AL
Publié: (2018)

Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
par: Rhee MK, et autres
Publié: (2017)

An assessment of the ocular tear film in patients with thyroid disorders
par: Alanazi SA, et autres
Publié: (2019)

Tear protein analysis in presumed congenital alacrima
par: Yaginuma S, et autres
Publié: (2018)

Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study
par: Aragona P, et autres
Publié: (2020)

Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study
par: Allam IY, et autres
Publié: (2021)

Severe symptoms of short tear break-up time dry eye are associated with accommodative microfluctuations
par: Kaido M, et autres
Publié: (2017)

Assessment of tear-evaporation rate in thyroid-gland patients
par: Abusharaha A, et autres
Publié: (2019)

Improving Tolerance and Compliance with Topical Immunomodulators Using Micro-Emulsion Lipid Layer Artificial Tears
par: Epitropoulos AT, et autres
Publié: (2020)

Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease
par: Nasser L, et autres
Publié: (2018)

Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
par: Molina-Solana P, et autres
Publié: (2020)

Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose
par: Wallerstein A, et autres
Publié: (2018)

Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
par: Fogagnolo P, et autres
Publié: (2020)

Six months' treatment with lifitegrast in patients with moderate-to-severe symptomatic dry eye: a retrospective chart review
par: Atallah RT, et autres
Publié: (2019)

Ocular Neuropathic Pain: An Overview Focusing on Ocular Surface Pains
par: Ebrahimiadib N, et autres
Publié: (2020)

Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study
par: McDonald MB, et autres
Publié: (2018)

Possible association between subtypes of dry eye disease and seasonal variation
par: Ayaki M, et autres
Publié: (2017)

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
par: Taylor M, et autres
Publié: (2019)